FDA gives green light to the first pill for post-partum depression

The U.S. Food and Drug Administration (FDA) has approved a new pill called Zuranolone to treat severe postpartum depression, offering hope for women struggling with this condition. Clinical trials showed significant improvements in depressive symptoms for those taking the medication daily over two weeks, with relief reported as early as three days and lasting for up to 45 days.